Real life long‐term efficacy and safety of ixekizumab in moderate‐to‐severe psoriasis: A 192 weeks multicentric retrospective study— <scp>IL PSO</scp> ( <scp>Italian</scp> landscape psoriasis)-Reference-Cited by-同舟云学术

Real life long‐term efficacy and safety of ixekizumab in moderate‐to‐severe psoriasis: A 192 weeks multicentric retrospective study— IL PSO ( Italian landscape psoriasis)

Published:2022-06-08 Issue:8 Volume:35 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Malagoli Piergiorgio¹,Dapavo Paolo²,Pavia Giulia³⁴^ORCID,Amoruso Fabrizio⁵,Argenziano Giuseppe⁶,Bardazzi Federico⁷,Burlando Martina⁸,Carrera Carlo G.⁹,Damiani Giovanni¹⁰^ORCID,Dini Valentina¹¹,Girolomoni Giampiero¹²,Guarneri Claudio¹³,Loconsole Francesco¹⁴,Narcisi Alessandra⁴,Sampogna Francesca¹⁵,Travaglini Massimo¹⁶,Costanzo Antonio³⁴

Affiliation:

1. Department of Dermatology Dermatology Unit Azienda Ospedaliera San Donato Milanese Milan Italy

2. Department of Biomedical Science and Human Oncology, Second Dermatologic Clinic University of Turin Turin Italy

3. Dermatology Unit, Department of Biomedical Sciences Humanitas University Pieve Emanuele Italy

4. Dermatology Unit Humanitas Clinical and Research Center – IRCCS Rozzano Italy

5. Dermatology Unit Azienda Ospedaliera di Cosenza Italy

6. Department of Dermatology 'Luigi Vanvitelli' University School of Medicine Naples Italy

7. Dermatology Unit, Department of Specialistic, Diagnostic and Experimental Medicine, S. Orsola‐Malpighi Hospital University of Bologna Bologna Italy

8. Section of Dermatology, Department of Health Sciences (DISSAL) IRCCS San Martino University Hospital Genoa Italy

9. Fondazione Cà Granda IRCCS Maggiore Policlinico Hospital Milan Italy

10. Clinical Dermatology I.R.C.C.S. Istituto Ortopedico Galeazzi Milan Italy

11. Dermatology Unit Department of Clinical and Experimental Medicine Ospedale Santa Chiara Pisa Italy

12. Department of Medicine, Section of Dermatology and Venereology University of Verona Verona Italy

13. Department of Biomedical and Dental Sciences and Morphofunctional Imaging University of Messina Messina Italy

14. Department of Dermatology University of Bari Bari Italy

15. Istituto Dermopatico Dell'Immacolata, (IDI) IRCCS Rome Italy

16. U.O.S.D. Dermatologica, Centro per la cura della psoriasi, Ospedale Perrino Brindisi Italy

Publisher

Hindawi Limited

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15608

Reference16 articles.

1. Global Epidemiology of Psoriasis: A Systematic Review of Incidence and Prevalence

2. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis

3. Immunology of Psoriasis

4. IL-17RD (Sef or IL-17RLM) interacts with IL-17 receptor and mediates IL-17 signaling

5. IL-17 and TNF Synergistically Modulate Cytokine Expression while Suppressing Melanogenesis: Potential Relevance to Psoriasis

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Interleukin 23/17 Axis in Psoriasis Management: A Comprehensive Review of Clinical Trials;Clinical, Cosmetic and Investigational Dermatology;2024-04

2. Drug survival, effectiveness and safety of ixekizumab for moderate‐to‐severe psoriasis up to 5 years;Journal of the European Academy of Dermatology and Venereology;2023-12-26

3. Ixekizumab for the treatment of moderate-to-severe plaque psoriasis: the first septennium;Immunotherapy;2023-10

4. Durability and long-term outcomes of biologic therapies in psoriasis;Expert Review of Clinical Immunology;2023-08-25

5. Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study);Journal of Dermatological Treatment;2023-08-17